Avid Bioservices Inc
NASDAQ:CDMO

Watchlist Manager
Avid Bioservices Inc Logo
Avid Bioservices Inc
NASDAQ:CDMO
Watchlist
Price: 12.275 USD -0.2% Market Closed
Market Cap: 785.1m USD
Have any thoughts about
Avid Bioservices Inc?
Write Note

Avid Bioservices Inc
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Avid Bioservices Inc
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Avid Bioservices Inc
NASDAQ:CDMO
Depreciation & Amortization
$12.5m
CAGR 3-Years
48%
CAGR 5-Years
34%
CAGR 10-Years
28%
Abbvie Inc
NYSE:ABBV
Depreciation & Amortization
$8.4B
CAGR 3-Years
-1%
CAGR 5-Years
34%
CAGR 10-Years
27%
Gilead Sciences Inc
NASDAQ:GILD
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Depreciation & Amortization
$5.6B
CAGR 3-Years
18%
CAGR 5-Years
23%
CAGR 10-Years
11%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Depreciation & Amortization
$219.7m
CAGR 3-Years
22%
CAGR 5-Years
17%
CAGR 10-Years
13%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Depreciation & Amortization
$469.5m
CAGR 3-Years
20%
CAGR 5-Years
19%
CAGR 10-Years
25%
No Stocks Found

Avid Bioservices Inc
Glance View

Market Cap
785.1m USD
Industry
Biotechnology

Avid Bioservices, Inc. engages in the commercial manufacturing. The company is headquartered in Tustin, California and currently employs 252 full-time employees. The firm is focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biopharmaceutical products derived from mammalian cell culture. The firm provides a range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The Company’s services include CGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The firm also provides process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.

CDMO Intrinsic Value
17.564 USD
Undervaluation 30%
Intrinsic Value
Price

See Also

What is Avid Bioservices Inc's Depreciation & Amortization?
Depreciation & Amortization
12.5m USD

Based on the financial report for Oct 31, 2024, Avid Bioservices Inc's Depreciation & Amortization amounts to 12.5m USD.

What is Avid Bioservices Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
28%

Over the last year, the Depreciation & Amortization growth was 35%. The average annual Depreciation & Amortization growth rates for Avid Bioservices Inc have been 48% over the past three years , 34% over the past five years , and 28% over the past ten years .

Back to Top